Rockefeller Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-900
| Closed | -$200K | – | 2031 |
|
|
2023
Q1 | $200K | Sell |
900
-44
| -5% | -$9.78K | ﹤0.01% | 1818 |
|
|
2022
Q4 | $262K | Buy |
944
+150
| +19% | +$41.6K | ﹤0.01% | 1541 |
|
|
2022
Q3 | $166K | Buy |
794
+465
| +141% | +$97.2K | ﹤0.01% | 1730 |
|
|
2022
Q2 | $76K | Buy |
329
+65
| +25% | +$15K | ﹤0.01% | 2092 |
|
|
2022
Q1 | $47K | Buy |
264
+10
| +4% | +$1.78K | ﹤0.01% | 2334 |
|
|
2021
Q4 | $54K | Buy |
254
+180
| +243% | +$38.3K | ﹤0.01% | 2188 |
|
|
2021
Q3 | $13K | Sell |
74
-825
| -92% | -$145K | ﹤0.01% | 2783 |
|
|
2021
Q2 | $161K | Sell |
899
-14
| -2% | -$2.51K | ﹤0.01% | 1599 |
|
|
2021
Q1 | $152K | Buy |
913
+72
| +9% | +$12K | ﹤0.01% | 1428 |
|
|
2020
Q4 | $127K | Buy |
841
+16
| +2% | +$2.42K | ﹤0.01% | 1353 |
|
|
2020
Q3 | $83K | Sell |
825
-300
| -27% | -$30.2K | ﹤0.01% | 1334 |
|
|
2020
Q2 | $136K | Buy |
1,125
+300
| +36% | +$36.3K | ﹤0.01% | 1066 |
|
|
2020
Q1 | $78K | Hold |
825
| – | – | ﹤0.01% | 1098 |
|
|
2019
Q4 | $73K | Hold |
825
| – | – | ﹤0.01% | 1054 |
|
|
2019
Q3 | $66K | Buy |
+825
| New | +$66K | ﹤0.01% | 899 |
|
|
2019
Q2 | – | Sell |
-251
| Closed | -$29K | – | 1989 |
|
|
2019
Q1 | $29K | Buy |
+251
| New | +$29K | ﹤0.01% | 1102 |
|